FDA Inspection 1255709 — Medac Gesellschaft Fur Klinische Spezialpraparate M.B.H.

Medac Gesellschaft Fur Klinische Spezialpraparate M.B.H. — FEI 3005261158

The FDA completed an inspection of Medac Gesellschaft Fur Klinische Spezialpraparate M.B.H. on May 9, 2023 in Wedel. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). Product area: Drugs.

Inspection details

Classification
Voluntary Action Indicated (VAI)
End Date
May 9, 2023
Fiscal Year
2023
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Wedel (Germany)

Additional details

Mutual Recognition Agreement (MRA)

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.